FDA inspection
Sun Deep Inc.: FDA inspection ending Dec 18, 2003
FDA inspection 307368 · Voluntary Action Indicated (VAI) · Hayward, CA
Key facts
| Inspection ID | 307368 |
|---|---|
| Firm | Sun Deep Inc. |
| FEI number | 1000523173 |
| Address | 31285 San Clemente St # B |
| City | Hayward |
| State | CA |
| ZIP | 94544-7814 |
| Fiscal year | 2004 |
| Inspection end date | Dec 18, 2003 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation |
| Product type | Drugs, Food/Cosmetics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data